跳至主要内容
临床试验/EUCTR2010-021815-18-IT
EUCTR2010-021815-18-IT进行中(未招募)不适用

Identification of the sentinel node in breast cancer with fluorescence lymphography using indocyanine green dye (ICG): pilot study.

ISTITUTO EUROPEO DI ONCOLOGIA0 个研究点目标入组 255 人开始时间: 2012年5月2日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
255

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Age = 18 years; - Cytologically or histologically diagnosis of breast cancer; - Primary tumor with a diameter = 3 cm; - Negative clinical evaluation of axilla; - Signed Informed Consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 255
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Hypersensitivity / known allergy to ICG, sodium iodide or iodine; - Hyperthyroidism; - Thyroid carcinoma; - Pregnancy and / or lactation; - Taking drugs that affect liver function; - Renal failure; - Taking medications that can alter the absorption of indocyanine-green; - Psychiatric disorders or any disease that compromises the ability to provide informed consent for participation in this study.

研究者

相似试验